Literature DB >> 7768389

Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study.

B Bernard1, J F Cadranel, D Valla, S Escolano, V Jarlier, P Opolon.   

Abstract

BACKGROUND/AIMS: In cirrhotic patients, bacterial infection is frequently associated with gastrointestinal bleeding and seems to increase mortality. The aims of this study were to determine the incidence of bacterial infections in bleeding cirrhotic patients and the influence of infections on the risk of rebleeding and death.
METHODS: Cirrhotic patients admitted for gastrointestinal bleeding who had not received antimicrobial chemotherapy in the previous 7 days were included. Blood, urine, and ascitic fluid cultures were systematically performed 1, 2, 4, and 7 days after admission.
RESULTS: Sixty-four patients were enrolled. Forty-two bacterial infections were documented in 23 patients (36%) within 7 days of admission. In patients with bacterial infection, mean Child-Pugh score and mean number of blood units transfused were significantly higher, early rebleeding was more frequent (43.5% vs. 9.8%; P < 0.01), and 4-week mortality was higher (47.8% vs. 14.6%; P < 0.01). Multivariate analysis only identified bacterial infections as predictive of early rebleeding (P < 0.02) and a high Child-Pugh score as predictive of death (P < 0.001).
CONCLUSIONS: In bleeding cirrhotic patients, bacterial infections only increase the risk of early rebleeding, and mortality is related to the severity of cirrhosis.

Entities:  

Mesh:

Year:  1995        PMID: 7768389     DOI: 10.1016/0016-5085(95)90146-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  58 in total

1.  UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology.

Authors:  R Jalan; P C Hayes
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

Review 2.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

3.  Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates.

Authors:  Matthew R L Brown; Graeme Jones; Kathryn L Nash; Mark Wright; Indra Neil Guha
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

4.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

Review 5.  Management of portal hypertension.

Authors:  D N Samonakis; C K Triantos; U Thalheimer; D W Patch; A K Burroughs
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

6.  Acute management and secondary prophylaxis of esophageal variceal bleeding: a western Canadian survey.

Authors:  Justin Cheung; Winnie Wong; Iman Zandieh; Yvette Leung; Samuel S Lee; Alnoor Ramji; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-08       Impact factor: 3.522

Review 7.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

8.  Spontaneous bacterial peritonitis: a review of treatment options.

Authors:  Cesar Alaniz; Randolph E Regal
Journal:  P T       Date:  2009-04

Review 9.  Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding.

Authors:  Yeong Yeh Lee; Hoi-Poh Tee; Sanjiv Mahadeva
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

10.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.